Cocrystal Pharma, Inc. (COCP)

1.21 +0.07 (+6.14%) USD  |  NASDAQ  |  Sep 18, 16:00
1.23 +0.02 (+1.65%) After-Hours: 20:00
More

Cocrystal Pharma Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for COCP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 20, 2026 --
June 25, 2026 --
June 01, 2026 --
May 27, 2026 --
April 07, 2026 --
April 06, 2026 --
February 23, 2026 --
February 20, 2026 --
December 31, 2025 --
November 18, 2025 --
October 23, 2025 --
September 17, 2025 --
August 19, 2025 --
August 15, 2025 --
June 20, 2025 --
May 27, 2025 --
May 19, 2025 --
Date Value
April 01, 2025 --
January 22, 2025 --
January 08, 2025 --
January 06, 2025 --
December 31, 2024 --
August 22, 2024 --
August 19, 2024 --
August 15, 2024 --
July 20, 2024 --
July 19, 2024 --
June 21, 2024 --
May 14, 2024 --
April 23, 2024 --
April 04, 2024 --
February 20, 2024 --
January 03, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
CNBX Pharmaceuticals, Inc. --
GB Sciences, Inc. --
Arvinas, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade
Definium Therapeutics, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade